UY28024A1 - Proceso para la preparación de (s.s)-cis-2-benshidril-3-bencilaminoquinuclidina - Google Patents
Proceso para la preparación de (s.s)-cis-2-benshidril-3-bencilaminoquinuclidinaInfo
- Publication number
- UY28024A1 UY28024A1 UY28024A UY28024A UY28024A1 UY 28024 A1 UY28024 A1 UY 28024A1 UY 28024 A UY28024 A UY 28024A UY 28024 A UY28024 A UY 28024A UY 28024 A1 UY28024 A1 UY 28024A1
- Authority
- UY
- Uruguay
- Prior art keywords
- organic
- acid
- chiral
- isomer
- cis
- Prior art date
Links
- 239000002253 acid Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000001735 carboxylic acids Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002466 imines Chemical class 0.000 abstract 2
- 150000002576 ketones Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41905102P | 2002-10-16 | 2002-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY28024A1 true UY28024A1 (es) | 2004-05-31 |
Family
ID=32108014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY28024A UY28024A1 (es) | 2002-10-16 | 2003-10-15 | Proceso para la preparación de (s.s)-cis-2-benshidril-3-bencilaminoquinuclidina |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6861526B2 (https=) |
| EP (1) | EP1551833A4 (https=) |
| JP (1) | JP2006506368A (https=) |
| KR (1) | KR100739901B1 (https=) |
| CN (1) | CN100418964C (https=) |
| AP (1) | AP2005003288A0 (https=) |
| AR (1) | AR041587A1 (https=) |
| AU (1) | AU2003277353B2 (https=) |
| BR (1) | BR0315335A (https=) |
| CA (1) | CA2500635A1 (https=) |
| EA (1) | EA008192B1 (https=) |
| HR (1) | HRP20050328A2 (https=) |
| IS (1) | IS7755A (https=) |
| MX (1) | MXPA05004058A (https=) |
| PA (1) | PA8586601A1 (https=) |
| PE (1) | PE20040777A1 (https=) |
| PL (1) | PL376218A1 (https=) |
| TN (1) | TNSN05111A1 (https=) |
| UY (1) | UY28024A1 (https=) |
| WO (1) | WO2004035575A1 (https=) |
| ZA (1) | ZA200502411B (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| JP5021318B2 (ja) * | 2004-01-30 | 2012-09-05 | ファイザー・プロダクツ・インク | β−シクロデキストリンを液体投薬形態に用いて多用量製剤を達成するための抗菌性防腐剤 |
| KR100812046B1 (ko) * | 2004-02-02 | 2008-03-10 | 화이자 프로덕츠 인크. | 1-(2ｓ,3ｓ)-2-벤즈히드릴-ｎ-(5-삼급-부틸-2-메톡시벤질)퀴누클리딘-3-아민의 제조 방법 |
| DE102004054054A1 (de) * | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| EP2540725A1 (de) | 2006-05-04 | 2013-01-02 | Boehringer Ingelheim International GmbH | Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CN102256976A (zh) | 2008-12-23 | 2011-11-23 | 贝林格尔.英格海姆国际有限公司 | 有机化合物的盐形式 |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| KR20240090632A (ko) | 2009-11-27 | 2024-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
| WO2011161161A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| US8883800B2 (en) | 2011-07-15 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| JP6218811B2 (ja) | 2012-05-14 | 2017-10-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
| CN108341812A (zh) * | 2017-01-23 | 2018-07-31 | 科贝源(北京)生物医药科技有限公司 | 一种含奎宁环化合物的制备方法 |
| CN108341811A (zh) * | 2017-01-23 | 2018-07-31 | 科贝源(北京)生物医药科技有限公司 | 马罗皮坦杂质的制备方法 |
| CN106977512B (zh) * | 2017-05-04 | 2019-01-01 | 海门慧聚药业有限公司 | 制备马罗匹坦游离碱的方法 |
| WO2025172911A1 (en) * | 2024-02-16 | 2025-08-21 | Teadus Pharmaceuticals Pvt. Ltd | A process for the preparation of (2s,3s)-2-benzhydryl- n-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3-amine and pharmaceutically acceptable salts thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3560510A (en) * | 1969-03-05 | 1971-02-02 | Aldrich Chem Co Inc | 2-benzhydrylquinuclidines |
| US4680283A (en) | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
| MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| US5138060A (en) | 1991-01-03 | 1992-08-11 | Pfizer Inc. | Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
| PL171921B1 (pl) | 1991-05-22 | 1997-06-30 | Pfizer | Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL |
| UA27776C2 (uk) * | 1991-05-31 | 2000-10-16 | Пфайзер Інк. | Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців |
| ATE208376T1 (de) | 1992-08-19 | 2001-11-15 | Pfizer | Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen |
| US5604241A (en) * | 1992-10-21 | 1997-02-18 | Pfizer Inc. | Substituted benzylaminoquinuclidines as substance P antagonists |
| JP2656699B2 (ja) | 1992-10-21 | 1997-09-24 | ファイザー製薬株式会社 | 置換ベンジルアミノキヌクリジン |
| JP2656700B2 (ja) | 1992-10-28 | 1997-09-24 | ファイザー製薬株式会社 | 置換キヌクリジン誘導体 |
| DK0668863T3 (da) * | 1992-11-12 | 1997-06-30 | Pfizer | Quinuclidinderivat som substans P-antagonist |
| IL109646A0 (en) | 1993-05-19 | 1994-08-26 | Pfizer | Heteroatom substituted alkyl benzylamino-quinuclidines |
| PE8798A1 (es) * | 1995-07-17 | 1998-03-02 | Pfizer | Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil] |
| MX9706944A (es) | 1996-09-12 | 1998-08-30 | Pfizer | Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p. |
-
2003
- 2003-10-06 US US10/679,961 patent/US6861526B2/en not_active Expired - Fee Related
- 2003-10-10 BR BR0315335-5A patent/BR0315335A/pt not_active IP Right Cessation
- 2003-10-10 AU AU2003277353A patent/AU2003277353B2/en not_active Ceased
- 2003-10-10 AR ARP030103709A patent/AR041587A1/es unknown
- 2003-10-10 WO PCT/US2003/032275 patent/WO2004035575A1/en not_active Ceased
- 2003-10-10 EA EA200500650A patent/EA008192B1/ru not_active IP Right Cessation
- 2003-10-10 PL PL03376218A patent/PL376218A1/xx not_active Application Discontinuation
- 2003-10-10 AP AP2005003288A patent/AP2005003288A0/xx unknown
- 2003-10-10 CA CA002500635A patent/CA2500635A1/en not_active Abandoned
- 2003-10-10 HR HR20050328A patent/HRP20050328A2/xx not_active Application Discontinuation
- 2003-10-10 EP EP03808986A patent/EP1551833A4/en not_active Withdrawn
- 2003-10-10 CN CNB200380101563XA patent/CN100418964C/zh not_active Expired - Fee Related
- 2003-10-10 JP JP2004544849A patent/JP2006506368A/ja active Pending
- 2003-10-10 MX MXPA05004058A patent/MXPA05004058A/es active IP Right Grant
- 2003-10-10 KR KR1020057006471A patent/KR100739901B1/ko not_active Expired - Fee Related
- 2003-10-14 PE PE2003001050A patent/PE20040777A1/es not_active Application Discontinuation
- 2003-10-15 UY UY28024A patent/UY28024A1/es not_active Application Discontinuation
- 2003-10-16 PA PA20038586601A patent/PA8586601A1/es unknown
-
2004
- 2004-10-27 US US10/974,447 patent/US20050085641A1/en not_active Abandoned
-
2005
- 2005-03-17 IS IS7755A patent/IS7755A/is unknown
- 2005-03-23 ZA ZA200502411A patent/ZA200502411B/en unknown
- 2005-04-15 TN TNP2005000111A patent/TNSN05111A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS7755A (is) | 2005-03-17 |
| US6861526B2 (en) | 2005-03-01 |
| HK1078087A1 (en) | 2006-03-03 |
| AU2003277353A1 (en) | 2004-05-04 |
| CA2500635A1 (en) | 2004-04-29 |
| EP1551833A4 (en) | 2010-06-02 |
| KR20050083764A (ko) | 2005-08-26 |
| EA200500650A1 (ru) | 2005-10-27 |
| BR0315335A (pt) | 2005-08-16 |
| ZA200502411B (en) | 2006-05-31 |
| EP1551833A1 (en) | 2005-07-13 |
| AR041587A1 (es) | 2005-05-26 |
| JP2006506368A (ja) | 2006-02-23 |
| PE20040777A1 (es) | 2004-11-20 |
| PA8586601A1 (es) | 2005-02-04 |
| PL376218A1 (en) | 2005-12-27 |
| MXPA05004058A (es) | 2005-06-08 |
| US20040116704A1 (en) | 2004-06-17 |
| CN100418964C (zh) | 2008-09-17 |
| HRP20050328A2 (en) | 2005-06-30 |
| TNSN05111A1 (en) | 2007-05-14 |
| WO2004035575A8 (en) | 2005-05-12 |
| KR100739901B1 (ko) | 2007-07-13 |
| WO2004035575A1 (en) | 2004-04-29 |
| EA008192B1 (ru) | 2007-04-27 |
| AU2003277353B2 (en) | 2007-08-09 |
| US20050085641A1 (en) | 2005-04-21 |
| AP2005003288A0 (en) | 2005-06-30 |
| CN1705664A (zh) | 2005-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28024A1 (es) | Proceso para la preparación de (s.s)-cis-2-benshidril-3-bencilaminoquinuclidina | |
| PE20091582A1 (es) | Procedimiento para la preparacion de dihidropteridinonas | |
| Enders et al. | Chemo-and Enantioselective Brønsted Acid-Catalyzed Reduction of α-Imino Esters with Catecholborane. | |
| CO5700735A2 (es) | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas | |
| ES2130083A1 (es) | Procedimiento para la obtencion de los enantiomeros de cizolirtina. | |
| MX376470B (es) | Método para producir flutemetamol. | |
| AR043505A1 (es) | Preparacion de beta-cetoamidas e intermediarios de reaccion | |
| Gu et al. | Organocatalytic Knoevenagel condensation by chiral C 2-symmetric tertiary diamines | |
| MY138457A (en) | Process for the preparation of a nickel/phosphorous ligand catalyst | |
| Davies et al. | Enantioselective synthesis of β-amino esters and its application to the synthesis of the enantiomers of the antidepressant Venlafaxine | |
| ATE380785T1 (de) | Herstellung eines neolignans mittels durch ddq vermittelte dimerisierung von dihydroasaron | |
| EA200701738A1 (ru) | Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина | |
| AR057022A1 (es) | Proceso para resolver un r o s acido mandelico a partir de su mezcla racemica | |
| TW200704630A (en) | Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same | |
| EA200201233A1 (ru) | Способ получения бифенильных соединений | |
| DE502005010080D1 (de) | Ingem chlorid-gehalt | |
| TR200201243T2 (tr) | Yüksek saflıkta sefpodoksim proksetil hazırlama yöntemi. | |
| RU2002108957A (ru) | Способ получения металлсодержащих углеродных наноструктур из органического соединения с добавками неорганических солей | |
| TR200002022T2 (tr) | Tramadolun arındırılması. | |
| AR047686A1 (es) | Un procedimiento de sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable | |
| RU2009128063A (ru) | Способ получения и выделения отдельных стереоизомеров 1-амино, 3-замещенных фенилциклопентанекарбоксилатов | |
| PA8594901A1 (es) | Proceso para la preparacion de (s,s)-cis-2-benzhidril-3-bencilaminoquinuclidina | |
| MD4443B1 (ro) | Procedeu de sinteză a 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-carbonitrilului şi aplicarea lui în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid acceptabil farmaceutic | |
| SE9802939D0 (sv) | New process | |
| BR0311409A (pt) | Processo para produção de modificações cristalinas especìficas de substâncias polimorfas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150129 |